Carregant...
How to tackle antimalarial resistance?
In the context of drug resistance, malaria is no exception. Even the latest artemisinins have started to lose their full efficacy in patients. Didier Leroy tells us about the strategies adopted by Medicines for Malaria Venture to reduce this terrible culprit. [Image: see text]
Guardat en:
| Publicat a: | EMBO Mol Med |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286390/ https://ncbi.nlm.nih.gov/pubmed/28028013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201607295 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|